Tag: Orsiro

Biotronik

Biotronik announces approval of new indications for drug-eluting stent

  Biotronik has today announced the approval of two new indications for the Orsiro Mission drug-eluting stent (DES):    One-month dual antiplatelet therapy (DAPT) for high...